Newsfeeds - Spark Newswire

1 minute read

Reuters Reported Thermo Fisher Scientific, South Korea’s Celltrion, KKR And Carlyle Group Said To Be Competing To Acquire The Biopharma Solutions Business Of Baxter International

By Charles Gross

March 20, 5:52 PM

https://www.reuters.com/markets/deals/thermo-fisher-celltrion-vie-baxters-biopharma-unit-sources-2023-03-20/

BAX

31 minute read

Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

March 10, 2:27 PM

On Friday, 497 companies set new 52-week lows.

AADI

1 minute read

Barclays Maintains Overweight on Baxter Intl, Lowers Price Target to $54

By Benzinga Newsdesk

February 13, 7:43 AM

Barclays analyst Matt Miksic maintains Baxter Intl (NYSE:BAX) with a Overweight and lowers the price target from $63 to $54.

BAX

1 minute read

Keybanc Maintains Overweight on Baxter Intl, Lowers Price Target to $52

By Benzinga Newsdesk

February 10, 5:31 AM

Keybanc analyst Matthew Mishan maintains Baxter Intl (NYSE:BAX) with a Overweight and lowers the price target from $60 to $52.

BAX

11 minute read

Earnings

Earnings Scheduled For February 9, 2023

By Benzinga Insights

February 9, 5:18 AM

Companies Reporting Before The Bell • AstraZeneca (NASDAQ:AZN) is expected to report quarterly earnings at $0.67 per share on revenue of $11.21 billion.

ABBV

1 minute read

Keybanc Maintains Overweight on Baxter Intl, Lowers Price Target to $60

By Benzinga Newsdesk

February 6, 4:50 AM

Keybanc analyst Matthew Mishan maintains Baxter Intl (NYSE:BAX) with a Overweight and lowers the price target from $73 to $60.

BAX

3 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

January 19, 2:35 PM

On Thursday, 29 stocks made new 52-week lows.

ARQQ

1 minute read

Wells Fargo Maintains Equal-Weight on Baxter Intl, Lowers Price Target to $52

By Benzinga Newsdesk

January 9, 10:35 AM

Wells Fargo analyst Larry Biegelsen maintains Baxter Intl (NYSE:BAX) with a Equal-Weight and lowers the price target from $57 to $52.

BAX

1 minute read

Baxter Plans Divesting Renal Care Business Into Separate Public Company, Shares Fall

By Vandana Singh

January 6, 2:33 PM

Baxter International Inc (NYSE:BAX) announced spinning off its Renal Care and Acute Therapies global business unit into an independent, publicly…

BAX

20 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For January 6, 2023

By Benzinga Insights

January 6, 11:00 AM

Upgrades Piper Sandler upgraded the previous rating for Aligos Therapeutics Inc (NASDAQ:ALGS) from Neutral to Overweight. Aligos Therapeutics…

AGTI